| Regulating Emotions and Behaviors After Brain Injury (NCT05393492) | University Hospital, Strasbourg, France | 2022-05-19 |
| The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis (NCT04372615) | University of Utah | 2022-03-30 |
| Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and Treatment (NCT04946682) | Wen-hong Zhang | 2021-04-14 |
| BIGlobal Intervention Study: Improving Diagnosis and Management of Suspected Brain Infections Globally (NCT04190303) | University of Liverpool | 2021-02-17 |
| Neurodegeneration Markers and Neurological Course in Severe Covid-19 Infection (NCT04361344) | Centre Hospitalier de PAU | 2020-05-19 |
| Neurological Features During COVID19 (NCT04460599) | Centre d'Investigation Clinique et Technologique 805 | 2020-03-08 |
| The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia (NCT04325685) | Northern State Medical University | 2020-01-01 |
| Core Cerebrospinal Fluid Biomarker Profile in Anti-Leucine Rich Glioma Inactivated 1 (Anti-LGI1) Encephalitis (NCT04001270) | Hospices Civils de Lyon | 2019-07-15 |
| Brazil ICU Encephalitis Surveillance (NCT05370573) | D'Or Institute for Research and Education | 2019-06-01 |
| Neurology Inpatient Clinical Education Trial (NCT03826056) | Dartmouth-Hitchcock Medical Center | 2019-02-01 |
| Venezuelan Equine Encephalitis Monovalent Virus-Like Particle Vaccine (NCT03776994) | SRI International | 2018-07-17 |
| The Effect of Closed Suction System on the Incidence of Ventilator-associated Pneumonia. (NCT04323150) | Northern State Medical University | 2018-02-01 |
| The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat) (NCT03710278) | Spartanburg Regional Healthcare System | 2017-12-21 |
| Epidemiology and Prognosis of Encephalitis in Intensive Care (NCT02906631) | Assistance Publique - Hôpitaux de Paris | 2017-10-27 |
| EURopean Study on Encephalitis in Intensive CAre (NCT03144570) | ICUREsearch | 2017-06-01 |
| Fosfomycin I.v. for Treatment of Severely Infected Patients (NCT02979951) | Infectopharm Arzneimittel GmbH | 2016-12-01 |
| Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort (NCT02910037) | University of California, San Francisco | 2016-06-01 |
| IL-2 in Refractory Autoimmune Encephalitis (NCT02714959) | Seoul National University Hospital | 2016-03-01 |
| Neurologic Manifestations of the Arbovirus Infection in Colombia (NCT03206541) | Johns Hopkins University | 2016-01-01 |
| Investigating the Role of Early Intravenous Immunoglobulin Treatment for Children With Encephalitis (NCT02308982) | University of Oxford | 2016-01-01 |
| Risk Factors and Outcomes of Immune-Mediated Encephalitis Following Exposure to Nivolumab (NCT02856451) | Bristol-Myers Squibb | 2015-12-09 |
| Central Nervous System Infections in Denmark (NCT03418441) | Aalborg University Hospital | 2015-01-01 |
| A Clinical Trial for Inactivated Japanese Encephalitis Vaccine in Healthy Chinese Infants (NCT02367664) | Jiangsu Province Centers for Disease Control and Prevention | 2014-10-01 |
| tDCS and Cognition in Adults With Multiple Sclerosis or Encephalitis (NCT02538094) | Johns Hopkins University | 2014-09-01 |
| SouthEast Asia Encephalitis Project (NCT04089436) | Institut Pasteur | 2014-07-15 |
| Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis (NCT04080921) | Vinmec Research Institute of Stem Cell and Gene Technology | 2014-06-16 |
| Immunogenicity of a Live Attenuated Chimeric JE Vaccine (IMOJEV) as a Booster Dose in Thai Children Primed With CD.JEVAX (NCT02526550) | Siriraj Hospital | 2014-06-01 |
| Nervous System Infections Among Patients With Febrile Seizure (NCT01694524) | Hôpital Armand Trousseau | 2013-06-01 |
| A Study of Japanese Encephalitis Chimeric Virus Vaccine Compared With SA14-14-2 Vaccine in Infants and Toddlers (NCT01092507) | Sanofi Pasteur, a Sanofi Company | 2010-03-01 |
| Safety and Immunogenicity of the Japanese Encephalitis Vaccine IC51 (IXIARO®) in a Pediatric Population (NCT01041573) | Valneva Austria GmbH | 2010-03-01 |
| Immunogenicity and Safety of the Japanese Encephalitis Vaccine IC51 (IXIARO®, JESPECT®) in a Pediatric Population in Non-endemic Countries (NCT01047839) | Valneva Austria GmbH | 2010-01-01 |
| Long-term Follow-up of Immunogenicity of a Single Dose of Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) in Toddlers (NCT01001988) | Sanofi Pasteur, a Sanofi Company | 2009-08-07 |
| Treatment of West Nile Virus With MGAWN1 (NCT00927953) | MacroGenics | 2009-05-01 |
| Pharmacokinetic Study of a Single Dose of AVI-4065 in Cerebral Spinal Fluid (NCT00381433) | Sarepta Therapeutics, Inc. | 2006-09-01 |
| Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis. (NCT00314132) | Sanofi | 2005-10-01 |
| Natural History of West Nile Virus Infection (NCT00069303) | National Institutes of Health Clinical Center (CC) | 2003-09-16 |
| A Study of ChimeriVax™-JE Live Attenuated Vaccine in Healthy Adults (NCT00981175) | Sanofi | 2003-04-01 |
| Long Term Treatment of Herpes Simplex Encephalitis (HSE) With Valacyclovir (NCT00031486) | National Institute of Allergy and Infectious Diseases (NIAID) | 2000-09-01 |
| Structure of the Herpes Simplex Virus Receptor (NCT00001648) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-08-20 |